Centogene Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 493

Employees

  • Latest Deal Type
  • Debt Refin.

  • Financing Rounds
  • 7

  • Investments
  • 3

Centogene General Information

Description

Centogene NV is a United States-based company engaged in data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. The company operates in two segments: pharmaceutical and diagnostics. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its diagnostics segment provides targeted genetic sequencing and diagnostics services to patients. Its geographic regions are Europe, the Middle East, North America, and Latin America.

Contact Information

Formerly Known As
Centogene Holding, Arcensus
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Am Strande 7
  • 18055 Rostock
  • Germany
+49 0381
Primary Industry
Drug Discovery
Other Industries
Diagnostic Equipment
Vertical(s)
Former Stock Listing
CNTGF
Corporate Office
  • Am Strande 7
  • 18055 Rostock
  • Germany
+49 0381

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Centogene Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Centogene‘s full profile, request access.

Request a free trial

Centogene Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Centogene NV is a United States-based company engaged in data-driven answers to patients, physicians, and pharmaceutical
Drug Discovery
Rostock, Germany
493 As of 2023

Waltham, MA
 

Ahmedabad, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Centogene Competitors (6)

One of Centogene’s 6 competitors is Revvity, a Corporation company based in Waltham, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Revvity Corporation Waltham, MA
Intas Pharmaceuticals Private Equity-Backed Ahmedabad, India
Personalis Formerly VC-backed Fremont, CA
CeGaT Corporate Backed or Acquired Tubingen, Germany
Genentech Formerly VC-backed South San Francisco, CA
To view Centogene’s complete competitors history, request access »

Centogene Patents

Centogene Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4495250-A1 Method for preparing an rna preparation and use thereof Inactive 18-Jul-2023
WO-2024175682-A1 Method for preparing an rna preparation and use thereof Inactive 21-Feb-2023
AU-2019214384-A1 Method for the diagnosis of hereditary angioedema Inactive 31-Jan-2018
CA-3089802-A1 Method for the diagnosis of hereditary angioedema Inactive 31-Jan-2018
EP-3521828-A1 Method for the diagnosis of hereditary angioedema Inactive 31-Jan-2018 G01N33/6893
To view Centogene’s complete patent history, request access »

Centogene Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Centogene Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Centogene‘s full profile, request access.

Request a free trial

Centogene Investments (3)

Centogene’s most recent deal was a Buyout/LBO with Pearl Medical Analysis Laboratory. The deal was made on 09-Jul-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Pearl Medical Analysis Laboratory 09-Jul-2026 Buyout/LBO Laboratory Services (Healthcare)
Joint venture (Centogene / Lifera) 26-Jun-2023 Joint Venture Other Healthcare Services
Provecs Medical (Laboratory facilities and equipment) 15-Apr-2020 Corporate Asset Purchase Buildings and Property
To view Centogene’s complete investments history, request access »

Centogene Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Pearl Medical Analysis Laboratory Abu Dhabi, United Arab Emirates

Centogene FAQs

  • When was Centogene founded?

    Centogene was founded in 2006.

  • Where is Centogene headquartered?

    Centogene is headquartered in Rostock, Germany.

  • What is the size of Centogene?

    Centogene has 493 total employees.

  • What industry is Centogene in?

    Centogene’s primary industry is Drug Discovery.

  • Is Centogene a private or public company?

    Centogene is a Private company.

  • What is Centogene’s current revenue?

    The current revenue for Centogene is .

  • How much funding has Centogene raised over time?

    Centogene has raised $129M.

  • Who are Centogene’s investors?

    Charme Capital Partners has invested in Centogene.

  • Who are Centogene’s competitors?

    Revvity, Intas Pharmaceuticals, Personalis, CeGaT, and Genentech are some of the 6 competitors of Centogene.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process